Get the Stockscreener App
7.63
0.26%
-0.02
Pre-market:
7.00
-0.63
-8.26%
Moolec Science Sa stock is traded at $7.63, with a volume of 8,479.
It is down -0.26% in the last 24 hours and down -14.56% over the past month.
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.
See More
Previous Close:
$7.65
Open:
$7.45
24h Volume:
8,479
Relative Volume:
0.04
Market Cap:
$5.54M
Revenue:
$7.83M
Net Income/Loss:
$-8.28M
P/E Ratio:
-0.4521
EPS:
-16.8761
Net Cash Flow:
$-6.85M
1W Performance:
+6.86%
1M Performance:
-14.56%
6M Performance:
+38.15%
1Y Performance:
-92.66%
1-Day Range:
$7.11
$7.73
1-Week Range:
$6.945
$7.99
52-Week Range:
$3.0765
$120.00
Moolec Science Sa Stock (MLEC) Company Profile
Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
7.63 | 5.54M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-27-23 | Initiated | ROTH MKM | Buy |
Moolec Science Sa Stock (MLEC) Latest News
Moolec Science (MLEC) Strengthens as Shares Approach Key Resistance LevelProtective Put - newsline.com
Number of shareholders of Moolec Science SA – NASDAQ:MLEC - TradingView
MLEC Q2 2025 Earnings: Narrower Loss Beats Estimates as SciTech Platform AdvancesEarnings Surprise Report - newsline.com
Number of shareholders of Moolec Science SA – NASDAQ:MLECW - TradingView
Why Did This Nano-Cap Food Stock More Than Double In Value Today? - Stocktwits
Moolec Science SA (MLEC) Q2 2025 Earnings: Narrowed Loss Surprises as Zero Revenue Path ContinuesForward EPS Estimate - newsline.com
MOOLEC SCIENCE SA (MLEC) Stock Chart - ChartMill
Moolec Science Regains Nasdaq Compliance but Faces Year-Long Monitoring - TipRanks
Moolec Science (MLEC) restores Nasdaq listing compliance but faces year of monitoring - Stock Titan
Moolec Science (MLEC) Gains 4.6% as Stock Approaches Key $7.91 Resistance LevelATR Stop - thelegaladvocate.com
MLEC Q2 2025 Earnings: Narrower-than-Expected Loss as Company Advances Science PlatformProduct Revenue Analysis - thelegaladvocate.com
MLEC Q2 2025 Earnings: Narrowed Loss Beats Estimates as Operational Progress ContinuesEarnings Revision Downgrade - newsline.com
Moolec Science (MLEC) Rallies 3.45% as Volume Picks Up, Approaches Key $7.88 ResistanceBreakaway Gap - newsline.com
Moolec Science (MLEC) Dips 2.81% as Shares Approach Key Support LevelInstitutional Sentiment - newsline.com
Moolec Science (MLEC) Slides 4.4% Amid Selling Pressure; Key Support at $7.06 in FocusSign of Weakness - newsline.com
MLEC Q2 2025 Earnings: Narrower Loss than Expected as Stock RisesPreliminary Results - The Legal Advocate
MLEC Q2 2025 Earnings: EPS Surprises to the Upside as Pre-Revenue Science Company Narrows LossEBITDA Margin Trends - Newser
Why Is Moolec Science S.A. (MLEC) Stock Down Today? - Meyka
MLEC Moolec EPS beats estimates but revenue plummets 285 yearoveryear shares declineSlow Growth Warning - The Legal Advocate
MSN Money - MSN
Moolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGM - TipRanks
Moolec Science shareholders approve financials, re-elect directors and auditor - Investing.com
[6-K] Moolec Science SA Current Report (Foreign Issuer) | MLEC SEC FilingForm 6-K - Stock Titan
Moolec Science completes 2026 safflower planting campaign By Investing.com - Investing.com South Africa
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026 - Meyka
Moolec Science completes 2026 safflower planting campaign - Investing.com
Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States - ACCESS Newswire
Safflower oil tops 60% GLA as Moolec finishes 2026 US planting push - Stock Titan
Moolec Science Swings to Profit on Subsidiary Deconsolidation in Latest Interim Results - TipRanks
Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base - TipRanks
Moolec hits $11.3M equity to satisfy Nasdaq listing rules - Stock Titan
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period - galvnews.com
Moolec Science (NASDAQ: MLEC) restores Nasdaq equity compliance - Stock Titan
TradingKey - TradingKey
MLEC stock extends its relentless rally, sees 35% boost today after change in shareholding - MSN
MLEC (Moolec) EPS beats estimates but revenue plummets 28.5% year-over-year, shares decline.IPO - newser.com
The working capital efficiency at Moolec (MLECW) | MLECW QX Earnings: Moolec Warrant Reports No Earnings DataDecline Phase - newser.com
MLEC Insider Filing: Director Core Daniel Joaquin Ownership Disclosure May 2026 - Meyka
MLECW Price History for Moolec Science Sa WT Stock - Barchart.com
MLEC SEC FilingsMoolec Science 10-K, 10-Q, 8-K Forms - Stock Titan
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Sahm
Moolec Science Sa Stock (MLEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):